Letter of Intent Deadline:
Sponsor:
UI Contact:
Updated Date:
Pre-Proposal required and due Dec. 19, 2023, before 3 p.m. Central Time.
Together, the American Heart Association (AHA) and Additional Ventures (AV) have established this jointly funded Request for Proposals (RFP) for the AHA/AV Collaborative Sciences Awards in Single Ventricle Heart Disease (CSAs).
The AHA and AV invite applications to the CSAs to support multidisciplinary, multi-institutional research teams to address key knowledge gaps in the clinical sequelae of single ventricle heart disease (SV) and its treatment paradigm (i.e., the Fontan circulation).
The AHA/AV CSAs are intended to foster innovative collaborative approaches to research projects that propose novel pairings of research teams from at least two broadly disparate disciplines – providing up to $2.25M in direct costs for teams of 2 to 4 labs each for projects lasting up to three years.
